Bristol-Myers Squibb buy The Goldman Sachs Group, Inc.
Start price
30.10.23
/
50%
€48.25
Target price
30.10.24
€65.03
Performance (%)
-19.17%
Price
31.05.24
€37.90
Summary
This prediction is currently active. The price of Bristol-Myers Squibb has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.17%. A total of €1.10 was paid as dividends for this prediction. This prediction currently runs until 30.10.24. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | -0.303% | -0.303% |
| iShares Core DAX® | -0.552% | 3.405% |
| iShares Nasdaq 100 | -1.415% | 4.613% |
| iShares Nikkei 225® | -0.877% | -1.396% |
| iShares S&P 500 | -0.415% | 3.338% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $81.00 to $69.00. They now have a "buy" rating on the stock.
Ratings data for BMY provided by MarketBeat